Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62.11 USD | -0.93% | +4.99% | -1.08% |
06-14 | Incyte Insider Sold Shares Worth $1,149,840, According to a Recent SEC Filing | MT |
06-13 | Incyte Reports Tender Offer Results | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.08% | 14.1B | |
+0.85% | 92.4B | |
-3.03% | 38.08B | |
-10.46% | 34.05B | |
+74.71% | 27.77B | |
-13.39% | 16B | |
-11.15% | 11.91B | |
+169.04% | 10.37B | |
-50.19% | 10.2B | |
+1.12% | 8.83B |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Incyte Says US FDA Approves BLA for Zynyz to Treat Merkel Cell Carcinoma; MacroGenics Achieves $15 Million Milestone